Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950103-23-017156
Filing Date
2023-12-04
Accepted
2023-12-04 16:57:53
Documents
7
Effectiveness Date
2023-12-04

Document Format Files

Seq Description Document Type Size
1 FORM S-8 dp203579_s8.htm S-8 50045
2 EXHIBIT 5 dp203579_ex05.htm EX-5 35646
3 EXHIBIT 23.2 dp203579_ex2302.htm EX-23.2 1781
4 EXHIBIT 99.1 dp203579_ex9901.htm EX-99.1 113463
5 EXHIBIT 99.2 dp203579_ex9902.htm EX-99.2 108862
6 EXHIBIT 107.1 dp203579_exfilingfees.htm EX-FILING FEES 19252
7 GRAPHIC image_001.jpg GRAPHIC 1340
  Complete submission text file 0000950103-23-017156.txt   332048
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275882 | Film No.: 231464043
SIC: 2834 Pharmaceutical Preparations